These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 3952537)
1. Isolated perfusion of extremities for metastatic melanoma from an unknown primary lesion. Muchmore JH; Krementz ET; Carter RD; Sutherland CM; Mendoza EA South Med J; 1986 Mar; 79(3):288-90. PubMed ID: 3952537 [TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for survival after isolated limb perfusion for malignant melanoma. Noorda EM; Vrouenraets BC; Nieweg OE; van Geel AN; Eggermont AM; Kroon BB Eur J Surg Oncol; 2003 Dec; 29(10):916-21. PubMed ID: 14624788 [TBL] [Abstract][Full Text] [Related]
3. [Preventive lymph node excision in the treatment concept of melanoma of the extremities]. Binder J; Henneking K Zentralbl Chir; 1996; 121(6):474-7. PubMed ID: 8767334 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant regional isolated perfusion with melphalan for patients with Clark V melanoma of the extremities. Vrouenraets BC; Kroon BB; Klaase JM; Van Geel BN; Eggermont AM; Franklin HR J Surg Oncol; 1993 Apr; 52(4):249-54. PubMed ID: 8468989 [TBL] [Abstract][Full Text] [Related]
5. Factors influencing the survival of patients with regional melanoma of the extremity treated by perfusion. Sutherland CM; Mather FJ; Krementz ET Surg Gynecol Obstet; 1987 Feb; 164(2):111-8. PubMed ID: 3810424 [TBL] [Abstract][Full Text] [Related]
6. The Effect of Temperature and Perfusion Time on Response, Toxicity, and Survival in Patients with In-transit Melanoma Metastases Treated with Isolated Limb Perfusion. Katsarelias D; Rådbo E; Ben-Shabat I; Mattsson J; Olofsson Bagge R Ann Surg Oncol; 2018 Jul; 25(7):1836-1842. PubMed ID: 29766389 [TBL] [Abstract][Full Text] [Related]
7. Chemotherapy by regional perfusion for limb melanoma. Krementz ET; Carter RD; Sutherland CM; Muchmore JH Am Surg; 1987 Mar; 53(3):133-40. PubMed ID: 3103506 [TBL] [Abstract][Full Text] [Related]
8. Lucy Wortham James lecture. Regional perfusion. Current sophistication, what next? Krementz ET Cancer; 1986 Feb; 57(3):416-32. PubMed ID: 3080216 [TBL] [Abstract][Full Text] [Related]
9. Regional isolated limb perfusion of melanoma intransit metastases using mechlorethamine (nitrogen mustard). Shiu MH; Knapper WH; Fortner JG; Yeh S; Horowitz G; Schnog J; Guerra J; Gould-Rossbach P; Ray C J Clin Oncol; 1986 Dec; 4(12):1819-26. PubMed ID: 3783205 [TBL] [Abstract][Full Text] [Related]
10. [Value of regional lymph node excision for prognosis of advanced malignant melanoma treated by perfusion of the extremity]. Huber R; Krüger I; Stützer H Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():118-21. PubMed ID: 9101808 [TBL] [Abstract][Full Text] [Related]
11. Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593. Koops HS; Vaglini M; Suciu S; Kroon BB; Thompson JF; Göhl J; Eggermont AM; Di Filippo F; Krementz ET; Ruiter D; Lejeune FJ J Clin Oncol; 1998 Sep; 16(9):2906-12. PubMed ID: 9738557 [TBL] [Abstract][Full Text] [Related]
13. Limb recurrence-free interval and survival in patients with recurrent melanoma of the extremities treated with normothermic isolated perfusion. Klaase JM; Kroon BB; van Geel AN; van Wijk J; Franklin HR; Eggermont AM; Hart AA J Am Coll Surg; 1994 Jun; 178(6):564-72. PubMed ID: 8193749 [TBL] [Abstract][Full Text] [Related]
18. A single centre's 10 year experience with isolated limb perfusion in the treatment of recurrent malignant melanoma of the limb. Lingam MK; Byrne DS; Aitchison T; MacKie RM; McKay AJ Eur J Cancer; 1996 Sep; 32A(10):1668-73. PubMed ID: 8983272 [TBL] [Abstract][Full Text] [Related]
19. Regional chemotherapy for melanoma. A 35-year experience. Krementz ET; Carter RD; Sutherland CM; Muchmore JH; Ryan RF; Creech O Ann Surg; 1994 Oct; 220(4):520-34; discussion 534-5. PubMed ID: 7944662 [TBL] [Abstract][Full Text] [Related]
20. Prognostic factors influencing tumor response, locoregional control and survival, in melanoma patients with multiple limb in-transit metastases treated with TNFalpha-based isolated limb perfusion. Di Filippo F; Giacomini P; Rossi CR; Santinami M; Anzà M; Garinei R; Perri P; Botti C; Di Angelo P; Sofra C; Pasqualoni R; Sperduti I; Cavaliere F; Di Filippo S; Corrias F; Armenti A; Ferraresi V; Ginebri A In Vivo; 2009; 23(2):347-52. PubMed ID: 19414425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]